On-Demand CME Videos

Open Up to New Treatments for Vitiligo: Online CME Activity

About

This activity was recorded at the Winter Clinical Dermatology Conference-Hawaii on January 17, 2023

 

CME Seminar in Depth - Open Up to New Treatments for Vitiligo


This activity is supported by an educational grant from Incyte. 

Availability

In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

January 17, 2023

Expiration Date:

January 17, 2024

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Recall the clinical trial data on JAK inhibitors for the management of vitiligo

  • Describe strategies to manage AE associated with JAK inhibitors

  • Discuss how to utilize JAK inhibitors in clinical practice for the management of vitiligo

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
Seemal
Seemal Desai, MD

Clinical Assistant Professor
Department of Dermatology
University of Texas Southwestern Medical Center
Dallas, TX

Susan
Susan Taylor, MD

Incoming President-elect, American Academy of Dermatology
Bernett L. Johnson Endowed Professor in Dermatology
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada and CMEsquared. The University of Nevada is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

CONFLICTS OF INTEREST/DISCLOSURES

In accordance with the ACCME Standards for Commercial Support, balance, independence, objectivity, and scientific rigor are ensured in all CME activities. This requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any ineligible companies. In addition, the content of this material has been approved by an independent peer reviewer. 

Disclosures are as follows:

Seemal R. Desai, MD

Grant/Research Support: AbbVie, Incyte, Dermavant, AOBiome,

Consultant: Galderma, Almirall, Ferndale, BMS, AbbVie, Verrica, UCB, Ortho, Scientis, EPI, Avita, Eli Lilly, Leo, Pfizer, Incyte, L’Oreal, Beiersdorf, J&J

Speakers’ Bureau or Honoraria: Dermavant, Galderma, Pfizer

The planners have disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.  

The University of Nevada discloses that all relevant conflicts have been satisfactorily mitigated.


Dermsquared

The leading platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2023 dermsquared | All Rights Reserved